The postmenopausal estrogen/breast cancer controversy

Area of Science:

• Endocrinology and Oncology
• Reproductive Health and Cancer Epidemiology

Background:

• The relationship between postmenopausal estrogen therapy and breast cancer risk remains a subject of debate.
• Conflicting findings in the literature necessitate a critical evaluation of study methodologies and potential biases.

Purpose of the Study:

• To synthesize existing evidence on postmenopausal estrogen use and breast cancer risk.
• To identify sources of disagreement in research findings and their clinical implications.
• To assess the impact of detection bias on risk estimates.

Main Methods:

• Systematic literature search of MEDLINE and review of bibliographies of relevant meta-analyses.
• Inclusion of 24 original articles and 3 meta-analyses.
• Focused review of 5 studies designed to minimize detection bias.

Main Results:

• Original articles showed variable risk estimates, ranging from protective to adverse effects.
• Meta-analyses did not reveal a significantly elevated overall risk of breast cancer with ever-use of estrogens.
• Studies controlling for detection bias indicated risk estimates of 1 or less for ever-users, with no consistent effects for other use categories.

Conclusions:

• Current evidence does not support an increased overall breast cancer risk associated with ever-using postmenopausal estrogens.
• Observed discrepancies may be attributed to cross-national variations in estrogen use and differential breast cancer detection rates.
• Further investigation into newer estrogen and progestin-opposed regimens is recommended.